Blocking CD24 through soluble CD24, consisting of the extracellular portion of murine CD24 and human IgG1 Fc ameliorated the clinical symptom of experimental autoimmune disease, the mouse model of multiple sclerosis [29]. Here, CD24 is linked to multiple sclerosis.